Both ANDIX and APHKX are mutual funds. ANDIX has a lower 5-year return than APHKX (3.28% vs 5.85%). ANDIX has a lower expense ratio than APHKX (0.55% vs 0.95%). Below is the comparison between ANDIX and APHKX.
ANDIX | APHKX | |
---|---|---|
Security Type | Mutual fund | Mutual fund |
Segment | International Equity: Foreign Large Blend | International Equity: Foreign Large Blend |
Family | AQR Funds | Artisan Partners Limited Partnership |
Net Assets | $106.00M | $15.63B |
Expense Ratio | 0.55% | 0.95% |
Management Style | active | active |
Dividend Yield | 2.83% | 3.05% |
Minimum Investment | $5,000,000.00 | N/A |
YTD Return | -12.06% | -8.54% |
1-Year Return | -6.65% | -8.71% |
3-Year Return | 3.99% | 9.87% |
5-Year Return | 3.28% | 5.85% |
10-Year Return | N/A | 9.63% |
ANDIX
ANDIX description
The Fund seeks total return. The Fund will invest at least 80% of its net assets in equity instruments includeing common stock, preffered stock, convertible securities, options, warrants, ETFs that invest in equity securities of International issuers.
ANDIX performance & returns
YTD Return | -12.06% |
1-Month Return | -5.66% |
3-Month Return | -6.65% |
1-Year Return | -6.65% |
3-Year Return | 3.99% |
5-Year Return | 3.28% |
10-Year Return | N/A |
ANDIX holdings
Top 10 Holdings (18.49% of Total Assets)
Name | Symbol | % Assets |
---|---|---|
Ubs Money Ser | N/A | 4.63% |
MSCI EAFE Index Future Dec 20 | MFSZ0.PA | 4.60% |
Woolworths Group Ltd | WOW | 1.31% |
L'Oreal SA | OR.AX | 1.31% |
Hoya Corp | 7741 | 1.16% |
Novo Nordisk A/S B | NOVO B | 1.12% |
Nestle SA | NESN | 1.11% |
Coloplast A/S B | COLO B | 1.09% |
Roche Holding AG Dividend Right Cert. | ROG | 1.08% |
CALBEE Inc | 2229 | 1.08% |
ANDIX pros
The following are ANDIX strengths from our perspective:
- Good news: this fund does not have 12b1, front-end or back-end sales fees.
ANDIX cons
The following are ANDIX weaknesses from our perspective:
- ANDIX net assets are $106.00 million. This fund is not a popular choice with retail investors.
- ANDIX 3-year return is 3.99%, which is lower than the 3-year return of the benchmark index (MSCI World ex USA NR USD), 5.11%.
- ANDIX 5-year return is 3.28%, which is lower than the 5-year return of the benchmark index (MSCI World ex USA NR USD), 4.06%.
- ANDIX expense ratio is 0.55%, which is not negligible. Is the fund expensive to you, and does it align to your investment strategy?
Other relevant ANDIX comparisons
You may also want to check out the following ANDIX comparisons that investors often look for on Finny
- ANDIX vs VGTSX
- ANDIX vs VTIAX
- ANDIX vs DODFX
- ANDIX vs VTSNX
- ANDIX vs VTPSX
- ANDIX vs VTMGX
- ANDIX vs APHKX
- ANDIX vs VDIPX
- ANDIX vs VTMNX
- ANDIX vs VTISX
APHKX
APHKX description
The Fund seeks maximum long-term capital growth by investing in a portfolio of undervalued non-U.S. companies.
APHKX performance & returns
YTD Return | -8.54% |
1-Month Return | -5.51% |
3-Month Return | -8.71% |
1-Year Return | -8.71% |
3-Year Return | 9.87% |
5-Year Return | 5.85% |
10-Year Return | 9.63% |
APHKX holdings
Top 10 Holdings (41.48% of Total Assets)
Name | Symbol | % Assets |
---|---|---|
Samsung Electronics Co Ltd | 005930.KS | 6.01% |
ABB Ltd | ABBN | 5.19% |
Compass Group PLC | CPG.L | 4.76% |
NAVER Corp | 035420.KS | 4.28% |
Arch Capital Group Ltd | ACGL | 3.81% |
UBS Group AG | UBSG | 3.79% |
Fresenius Medical Care AG & Co. KGaA | FME.DE | 3.58% |
Novartis AG | NOVN | 3.46% |
HCL Technologies Ltd | HCLTECH.BO | 3.30% |
Cie Financiere Richemont SA | CFR | 3.30% |
APHKX pros
The following are APHKX strengths from our perspective:
- APHKX 3-year return is 9.87%, which is higher than the 3-year return of the benchmark index (MSCI EAFE NR USD), 4.46%.
- APHKX 5-year return is 5.85%, which is higher than the 5-year return of the benchmark index (MSCI EAFE NR USD), 3.54%.
- APHKX 10-year return is 9.63%, which is higher than the 10-year return of the benchmark index (MSCI EAFE NR USD), 6.6%.
- APHKX 15-year return is 6.25%, which is higher than the 15-year return of the benchmark index (MSCI EAFE NR USD), 1.91%.
- Good news: this fund does not have 12b1, front-end or back-end sales fees.
APHKX cons
The following are APHKX weaknesses from our perspective:
- APHKX expense ratio is 0.95%, which is not negligible. Is the fund expensive to you, and does it align to your investment strategy?
Other relevant APHKX comparisons
You may also want to check out the following APHKX comparisons that investors often look for on Finny
- APHKX vs VGTSX
- APHKX vs VTIAX
- APHKX vs DODFX
- APHKX vs VTSNX
- APHKX vs VTPSX
- APHKX vs VTMGX
- APHKX vs VDIPX
- APHKX vs VTMNX
- APHKX vs VTISX
- APHKX vs TCIEX